Article
Eravacycline activity against clinical S. aureus isolates from China: in vitro activity, MLST profiles and heteroresistance
1 Dec 2018
Abstract excerpt
BACKGROUND: Mortality rates for patients with Staphylococcus aureus (S. aureus) infections have improved only modestly in recent decades and S. aureus infections remain a major clinical challenge This study investigated the in vitro antimicrobial activity of erevacycline (erava) against clinical S. aureus isolates from China, as well as the heteroresistance frequency of erava and sequence types (STs) represented...